News Center
September 18, 2024
Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0
- By Variantyx
- Posted in Press Releases
FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
April 26, 2024
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
- By Variantyx
- Posted in Press Releases
FRAMINGHAM, Mass. April 26, 2024 (Business Wire) – Variantyx, a leader in molecular diagnostics, announced today that it has secured...
November 30, 2023
Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
- By Variantyx
- Posted in Press Releases
FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023
Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
- By Variantyx
- Posted in Press Releases
FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023
Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint
- By Variantyx
- Posted in Press Releases
FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
February 12, 2022
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
- By Variantyx
- Posted in Press Releases
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
November 12, 2021
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
- By STUTTGART
- Posted in Press Releases
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...
March 15, 2021
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
- By Variantyx
- Posted in Press Releases
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...
January 26, 2021
Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market
- By Variantyx
- Posted in Press Releases
January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...